ArticleCancer management and research2021

MiR-183-5p Promotes Tumor Progression of Osteosarcoma and Predicts Poor Prognosis in Patients.

Lin Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.